CXCL12/CXCR4 modulates macrophage efferocytosis to induce glomerular crescent formation and fibrosis via ELMO1/DOCK180/RAC1 signaling in ANCA-associated glomerulonephritis

This study revealed that CXCL12/CXCR4 signaling axis plays a key regulatory role in the pathological process of AAGN. By establishing the specific molecular dialogue mechanism between endothelial cells and monocytes/macrophages, CXCL12 released by apoptotic endothelial cells can activate the CXCR4 on the surface of monocytes/macrophages, thereby promoting monocyte migration, enhancing macrophage-mediated efferocytosis and transforming into a pro-fibrotic phenotype. Targeted intervention with CXCL12/CXCR4 provides a promising approach for the treatment of AAGN.

Authors

Institutions

Publication Details

Journal
Cellular and Molecular Life Sciences
Published
2025-07-19
DOI
https://doi.org/10.1007/s00018-025-05750-5
Primary Topic
Renal Diseases and Glomerulopathies
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CXCL12/CXCR4 modulates macrophage efferocytosis to induce glomerular crescent formation and fibrosis via ELMO1/DOCK180/RAC1 signaling in ANCA-associated glomerulonephritis

Yongqi Deng, Shuo Wei, Mo Wang, Haohuan Li et al.
Cellular and Molecular Life Sciences
Renal Diseases and Glomerulopathies
article

CXCL12/CXCR4 modulates macrophage efferocytosis to induce glomerular crescent formation and fibrosis via ELMO1/DOCK180/RAC1 signaling in ANCA-associated glomerulonephritis

Yongqi Deng, Shuo Wei, Mo Wang, Haohuan Li, Hua-Ying Xiong, Xin Cai, Xiong Wang, Wei Jiang, Qiulin Li, Yaxi Chen, Qiu Li, Liwen Tan, Xiaomei Song
article en

Abstract

This study revealed that CXCL12/CXCR4 signaling axis plays a key regulatory role in the pathological process of AAGN. By establishing the specific molecular dialogue mechanism between endothelial cells and monocytes/macrophages, CXCL12 released by apoptotic endothelial cells can activate the CXCR4 on the surface of monocytes/macrophages, thereby promoting monocyte migration, enhancing macrophage-mediated efferocytosis and transforming into a pro-fibrotic phenotype. Targeted intervention with CXCL12/CXCR4 provides a promising approach for the treatment of AAGN.

Cellular and Molecular Life SciencesVol. 82(1)
Dalian Medical University (CN), Second Affiliated Hospital of Chongqing Medical University (CN), Children's Hospital of Chongqing Medical University (CN), Chongqing Medical University (CN)
National Natural Science Foundation of China, Natural Science Foundation of Chongqing, Key Technologies Research and Development Program
Openalex Percentile: Top 80%
Renal Diseases and Glomerulopathies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

CXCL12/CXCR4 modulates macrophage efferocytosis to induce glomerular crescent formation and fibrosis via ELMO1/DOCK180/RAC1 signaling in ANCA-associated glomerulonephritis — Yongqi Deng, Shuo Wei, et al. · Cellular and Molecular Life Sciences (2025) | TGRS Research Map | TGRS